JPMorgan Chase Bank, N.A. v. Avara US Holdings LLC

CourtDistrict Court, S.D. New York
DecidedFebruary 21, 2024
Docket1:23-cv-07145
StatusUnknown

This text of JPMorgan Chase Bank, N.A. v. Avara US Holdings LLC (JPMorgan Chase Bank, N.A. v. Avara US Holdings LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
JPMorgan Chase Bank, N.A. v. Avara US Holdings LLC, (S.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ────────────────────────────────────

JPMORGAN CHASE BANK, N.A., 23-cv-7145 (JGK) Plaintiff, MEMORANDUM OPINION AND - against - ORDER

AVARA US HOLDINGS LLC,

Defendant.

────────────────────────────────────

JOHN G. KOELTL, District Judge:

There are two motions pending before this Court. The first motion is a motion to dismiss by the defendant, Avara US Holdings LLC (“Avara US”), arguing that this action should be dismissed pursuant to Federal Rule of Civil Procedure 12(b)(1) and the Colorado River abstention doctrine. ECF No. 37. The second motion is a motion for partial summary judgment on Counts I, II, and III of the complaint by the plaintiff, JPMorgan Chase Bank, N.A. (“JPMorgan”), pursuant to Federal Rule of Civil Procedure 56. ECF No. 6. The plaintiff seeks judgment on its breach of contract claim and declaratory judgment that the plaintiff is entitled to foreclose on and/or exercise proxy rights related to the pledged equity interests of the defendant. For the reasons explained below, the defendant’s motion pursuant to the Colorado River abstention doctrine is granted, but the case is stayed rather than dismissed. The plaintiff’s motion for partial summary judgment is denied without prejudice. I.

A. Background Avara Pharmaceutical Services Ltd. (together with its affiliates, “Avara”) is a manufacturer of compounds and products for pharmaceutical companies. Declaration of Leonard M. Levie (“Levie Decl.”) ¶¶ 3–4, ECF No. 39. Defendant Avara US is an affiliate holding company that owns 100% of the shares of Avara Pharmaceutical Technologies, Inc. (“Avara Norman”), an affiliate that owns and operates a manufacturing facility in Norman, Oklahoma. Id. ¶¶ 9, 13. Avara US has no employees, operations, or current business purpose other than as a holding company for Avara Norman’s equity and the equity of other Avara subsidiaries. Id. ¶ 15. Avara US alleges that its only

substantial asset is its equity in Avara Norman. Id. ¶ 14. JPMorgan alleges that Avara US downplays the value of its other assets -- 100% of the shares of Avara Aiken Pharmaceutical Services, Inc. (“Avara Aiken”) and Avara Pharmaceutical Services, Inc. -- because Avara Aiken has significant value. Declaration of Matthew H. Massie ¶ 14, ECF No. 64. On May 25, 2018, Avara entered into a credit agreement with JPMorgan (as administrative agent, issuing bank, and sole lender) for an initial credit facility totaling $25 million with an original maturity date of May 25, 2020. Def.’s Resp. to Pl.’s Rule 56.1 Statement (“Def.’s 56.1 Resp.”) ¶¶ 1, 3-4, ECF No. 50. As security for this loan, Avara granted JPMorgan security over

assets of Avara, including assets of Avara US, Avara Norman, Avara Avlon Pharmaceutical Services Ltd. (“Avara Avlon”), and Avara Shannon Pharmaceutical Services Ltd. (“Avara Shannon”). Id. ¶¶ 5-6, 9. On or about May 21, 2020, Avara and JPMorgan amended the credit agreement to extend the maturity date to June 9, 2020. Id. ¶ 7. On June 9, 2020, the parties entered into an Amended Credit Agreement (together with the Amended Pledge and Security Agreement, the “Agreement”). Id. ¶ 8; see also Declaration of Christopher Harris (“Harris Decl.”), Ex. 4, ECF No. 8-4. JPMorgan alleges that, when the parties entered into the Amended Credit Agreement, the parties agreed to remove Avara Avlon and

Avara Shannon -- located in the United Kingdom and Ireland, respectively -- as loan guarantors, as reflected in the listing of Avara Avlon and Avara Shannon as “excluded subsidiaries” under the Agreement. Def.’s 56.1 Resp. ¶ 9. Avara US alleges that the parties understood that, although Avara Avlon and Avara Shannon were listed as excluded subsidiaries, JPMorgan would still hold liens over their assets. Id. The Amended Credit Agreement contained a maturity date of August 31, 2021. Id. ¶ 10. On or about August 31, 2021, the maturity date was extended to November 30, 2021. Id. ¶ 17. B. Allegations of Breach

JPMorgan alleges that the loans matured on November 30, 2021, and Avara failed to repay the outstanding loans in the amount of $21.325 million, which resulted in default. Id. ¶¶ 45- 46, 48. On or about December 2, 2021, JPMorgan provided notice of default to Avara US and certain affiliates. Id. ¶ 48. On the other hand, Avara US alleges that JPMorgan first breached the Agreement by failing to perfect properly and protect its collateral rights in the assets of Avara Avlon, which entered administration and then liquidation. Harris Decl., Ex. 13, ¶¶ 73-78, ECF No. 8-13 (“SDNY Compl.”). Instead, Avara US alleges, JPMorgan refused to collect the Avara Avlon cash collateral, refused to transfer its secured claims to Avara to

collect the cash collateral and repay the loan, and released the collateral in breach of the Agreement, receiving none of the proceeds from the $25 million sale of Avara Avlon’s assets. Id. Avara US alleges that those rights, if enforced, would have substantially -- if not entirely -- reduced the amounts allegedly owed to JPMorgan. Id. ¶ 78. For its part, JPMorgan claims that Avara agreed that JPMorgan has the unilateral right to choose which collateral to pursue or not pursue, Avara waived any defenses or claims based on JPMorgan’s decisions regarding any such collateral, Avara had already agreed to drop Avara Avlon and Avara Shannon as loan guarantors before the alleged default occurred, and any alleged lien release did not breach

the Agreement. Def.’s 56.1 Resp. ¶¶ 18-43. Avara US also alleges that JPMorgan breached the Agreement by failing either to grant Avara’s request for an extension of the maturity date or to permit Avara to find a new lender. SDNY Compl. ¶¶ 3, 88, 154. More specifically, after Avara exercised its alleged right to request an extension, JPMorgan purported to negotiate over the extension, but when the then-stated maturity date passed without JPMorgan’s agreeing to or rejecting the extension request, JPMorgan declared the loan in default and stopped collecting automatic payments of principal and interest from Avara’s checking account at JPMorgan. Id. ¶ 88. Avara US also alleges that JPMorgan and Avara subsequently agreed on the

material terms of an eighteen-month extension of the maturity date, but that agreement failed because JPMorgan conditioned any extension on Avara’s releasing all claims against JPMorgan relating to its abandonment and release of the Avara Avlon collateral. Id. ¶ 90. JPMorgan counters that it had no obligation to extend the maturity date or continue negotiations. Def.’s 56.1 Resp. ¶ 41. Avara US also alleges that JPMorgan, through all of the above-mentioned actions, breached the implied covenant of good faith and fair dealing. Id. ¶ 193. C. Litigation On August 17, 2022, JPMorgan filed a verified petition in Oklahoma state court against Avara Norman to foreclose on the

mortgage and security interest over Avara Norman’s real property and assets and to appoint a receiver over Avara Norman. Id. ¶ 182; see also Harris Decl., Ex. 9, ECF No. 8-9 (“Okla. Pet.”). In response, Avara filed an action in this District (“the SDNY action”) on November 7, 2022. Avara moved for a temporary restraining order and a preliminary injunction, seeking to restrain JPMorgan from proceeding with the Oklahoma action based on the forum selection clause of the Agreement. The motion was denied the same day. Harris Decl., Ex. 12, ECF No. 8-12. On November 10 and December 9, 2022, the Oklahoma court held two days of evidentiary hearings on JPMorgan’s motion for expedited appointment of a receiver. Def.’s 56.1 Resp. ¶ 188.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

GoldenTree Asset Management, L.P. v. Longaberger Co.
448 F. Supp. 2d 589 (S.D. New York, 2006)
Radioactive, J v. v. Manson
153 F. Supp. 2d 462 (S.D. New York, 2001)
Mouchantaf v. INTERNATIONAL MODELING AND TALENT ASSOCIATION
368 F. Supp. 2d 303 (S.D. New York, 2005)
Bank of New York v. Bin Saud
628 F. Supp. 474 (S.D. New York, 1986)
Phillips v. Citibank, N.A.
252 F. Supp. 3d 289 (S.D. New York, 2017)
Sitgraves v. Federal Home Loan Mortgage Corp.
265 F. Supp. 3d 411 (S.D. New York, 2017)
Telesco v. Telesco Fuel & Masons' Materials, Inc.
765 F.2d 356 (Second Circuit, 1985)
Bethlehem Contracting Co. v. Lehrer/McGovern, Inc.
800 F.2d 325 (Second Circuit, 1986)
De Cisneros v. Younger
871 F.2d 305 (Second Circuit, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
JPMorgan Chase Bank, N.A. v. Avara US Holdings LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jpmorgan-chase-bank-na-v-avara-us-holdings-llc-nysd-2024.